ID: ALA1631726

Max Phase: Preclinical

Molecular Formula: C15H16N4S

Molecular Weight: 284.39

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C/C(=N\NC(=S)Nc1ccc(C)cc1)c1ccccn1

Standard InChI:  InChI=1S/C15H16N4S/c1-11-6-8-13(9-7-11)17-15(20)19-18-12(2)14-5-3-4-10-16-14/h3-10H,1-2H3,(H2,17,19,20)/b18-12+

Standard InChI Key:  ZKSCCNZKLCCYNG-LDADJPATSA-N

Associated Targets(Human)

MES-SA 905 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MES-SA/Dx5 643 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

KB 3-1 1143 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

KB-V1 202 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

A2780 11979 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HFF 3142 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Plasmodium berghei 192651 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 284.39Molecular Weight (Monoisotopic): 284.1096AlogP: 3.10#Rotatable Bonds: 3
Polar Surface Area: 49.31Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.30CX Basic pKa: 2.88CX LogP: 3.43CX LogD: 3.43
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.52Np Likeness Score: -2.17

References

1. Lessa JA, Mendes IC, da Silva PR, Soares MA, dos Santos RG, Speziali NL, Romeiro NC, Barreiro EJ, Beraldo H..  (2010)  2-Acetylpyridine thiosemicarbazones: cytotoxic activity in nanomolar doses against malignant gliomas.,  45  (12): [PMID:20884094] [10.1016/j.ejmech.2010.09.021]
2. PubChem BioAssay data set, 
3. Klayman DL, Bartosevich JF, Griffin TS, Mason CJ, Scovill JP..  (1979)  2-Acetylpyridine thiosemicarbazones. 1. A new class of potential antimalarial agents.,  22  (7): [PMID:376848] [10.1021/jm00193a020]
4. Pape VF,Tóth S,Füredi A,Szebényi K,Lovrics A,Szabó P,Wiese M,Szakács G.  (2016)  Design, synthesis and biological evaluation of thiosemicarbazones, hydrazinobenzothiazoles and arylhydrazones as anticancer agents with a potential to overcome multidrug resistance.,  117  [PMID:27161177] [10.1016/j.ejmech.2016.03.078]